$41.86
0.39[0.94%]
At close: Apr 26
$41.86
0[0.00%]
After Hours: 4:00PM EDT
iRadimed
(NASDAQ:IRMD)Latest News for iRadimed Stock (NASDAQ:IRMD)
iRadimed Stock (NASDAQ: IRMD)
Categories: All
Monday, April 22, 2024
Wednesday, April 03, 2024
Thursday, February 08, 2024
- IRadimed Forecasts FY24 Revenue of $72M-$74M, With Adjusted EPS Of $1.52-$1.62 Compared To Consensus Of $71.50M And $1.48, RespectivelyBenzinga Newsdesk - Feb 8, 2024, 8:10AM
- IRadimed Forecasts Q1 FY24 Revenue of $17M-$17.3M, With Adjusted EPS Of $0.33-$0.35 Compared To Consensus Of $16.50M And $0.32, RespectivelyBenzinga Newsdesk - Feb 8, 2024, 8:08AM
- iRadimed Q4 Adjusted EPS $0.39 Misses $0.40 Estimate, Sales $17.45M Beat $17.33M EstimateBenzinga Newsdesk - Feb 8, 2024, 8:06AM
- Earnings Scheduled For February 8, 2024Benzinga Insights - Feb 8, 2024, 4:43AM
Wednesday, February 07, 2024
Tuesday, January 09, 2024
Monday, December 18, 2023
Friday, November 03, 2023
- IRADIMED shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 adjusted EPS guidance above estimates. Also, the company issued FY23 guidance above estimates.Benzinga Newsdesk - Nov 3, 2023, 12:24PM
- IRADIMED Sees FY23 Adjusted EPS Of $1.48-$1.51 Versus Consensus Of $1.26 And Prior Range Of $1.37-$1.40Benzinga Newsdesk - Nov 3, 2023, 8:09AM
- IRADIMED Sees FY23 Revenue Of $65.0M-$65.5M Versus Consensus Of $64.77M And Prior Range Of $64.5M-$65.5MBenzinga Newsdesk - Nov 3, 2023, 8:08AM
- IRADIMED Sees Q4 FY23 Adjusted EPS Of $0.38-$0.41 Versus Consensus Of $0.33Benzinga Newsdesk - Nov 3, 2023, 8:05AM
- IRADIMED Sees Q4 FY23 Revenue Of $16.9M-$17.4M Versus Consensus Of $17.01MBenzinga Newsdesk - Nov 3, 2023, 8:04AM
- iRadimed Q3 Adjusted EPS $0.43 Beats $0.36 Estimate, Sales $16.50M Beat $16.17M EstimateBenzinga Newsdesk - Nov 3, 2023, 8:02AM
- Earnings Scheduled For November 3, 2023Benzinga Insights - Nov 3, 2023, 7:12AM
Thursday, November 02, 2023
Friday, October 13, 2023
Thursday, August 03, 2023
- IRadimed Corporation shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 and FY23 guidance above estimates.Benzinga Newsdesk - Aug 3, 2023, 3:07PM
- IRadimed Expects FY23 Revenue Of $64.5M-$65.5M Vs. Prior Guidance Of $62M-$63.5M And Consensus Of $63.09M; It Sees Adjusted EPS Of $1.37-$1.40 Vs. Previous Outlook Of $1.26-$1.35 And Consensus Of $1.30Benzinga Newsdesk - Aug 3, 2023, 8:12AM
- IRadimed Expects Q3 FY23 Revenue Of $16.1M-$16.3M Vs. Consensus Of $15.6M; Sees Adjusted EPS OF $0.36-$0.38 Vs. Consensus Of $0.33Benzinga Newsdesk - Aug 3, 2023, 8:08AM
- iRadimed Q2 Adjusted EPS $0.36 Beats $0.31 Estimate, Sales $16.13M Beat $15.65M EstimateBenzinga Newsdesk - Aug 3, 2023, 8:02AM
- Earnings Scheduled For August 3, 2023Benzinga Insights - Aug 3, 2023, 6:59AM
Thursday, June 08, 2023
Tuesday, May 09, 2023
Thursday, May 04, 2023
- iRadimed: Q1 Earnings InsightsBenzinga Insights - May 4, 2023, 9:30AM
- iRadimed Boosts FY23 Revenue Guidance From $61.0M-$63.0M To $62M-$63.5M (Consensus $62.51M) , Adj. EPS From $1.23-$1.34 To $1.26-$1.35 (Consensus $1.31)Benzinga Newsdesk - May 4, 2023, 8:35AM
- iRadimed Expects Q2 Revenue Of $15.6M-$15.8M (Consensus $15.1M), Adjusted EPS Of $0.30-$0.32 (Consensus $0.30)Benzinga Newsdesk - May 4, 2023, 8:33AM
- iRadimed Q1 Adj EPS $0.30 Beats $0.28 Estimate, Sales $15.47M Beat $14.77M EstimateBenzinga Newsdesk - May 4, 2023, 8:31AM
- Earnings Scheduled For May 4, 2023Benzinga Insights - May 4, 2023, 6:34AM
Wednesday, May 03, 2023
Monday, February 27, 2023
Friday, February 24, 2023
Thursday, February 02, 2023
- IRADIMED Expects FY23 Adjusted EPS Of $1.23-$1.34 Compared To Consensus Of $1.30, Expects Sales Of $61M-$63M Vs. Consensus Of $62.84MBenzinga Newsdesk - Feb 2, 2023, 8:15AM
- IRADIMED's Board Has Approved Special Cash Dividend Of $1.05/Share Payable On February 21, 2023, For Record Date Of February 13, 2023Benzinga Newsdesk - Feb 2, 2023, 8:10AM
- iRadimed Q4 Adjusted EPS $0.32 Beats $0.30 Estimate, Sales $14.86M Miss $14.87M EstimateBenzinga Newsdesk - Feb 2, 2023, 8:03AM
Wednesday, February 01, 2023
Wednesday, January 18, 2023
Tuesday, November 22, 2022
Thursday, November 03, 2022
- IRADIMED CORPORATION Reiterated Q4 Revenue Guidance $14.1M-$14.8M; Q4 Non-GAAP EPS $0.25-$0.30; FY22 Revenue Guidance $52.5M-$53.2M; FY22 Non-GAAP EPS $1.03-$1.08Benzinga Newsdesk - Nov 3, 2022, 8:54AM
- Recap: iRadimed Q3 EarningsBenzinga Insights - Nov 3, 2022, 7:46AM
- iRadimed Q3 Adj. EPS $0.29 Beats $0.24 Estimate, Sales $13.40M Beat $13.19M EstimateBenzinga Newsdesk - Nov 3, 2022, 7:09AM
- Earnings Scheduled For November 3, 2022Benzinga Insights - Nov 3, 2022, 5:42AM
Wednesday, November 02, 2022
Wednesday, October 12, 2022
Tuesday, October 11, 2022
Monday, October 10, 2022
- Iradimed Withdraws FDA Application For Updated MR IV Pump SystemVandana Singh - Oct 10, 2022, 11:24AM
- IRADIMED Sees Prelim. Q3 Sales $13.4M vs $13.19M Est.Bill Haddad - Oct 10, 2022, 8:02AM
- IRADIMED CORPORATION Withdraws 510(k) With Plans To Resubmit After Further Discussions With FDABill Haddad - Oct 10, 2022, 8:00AM